SCHEMBL23210710

SCHEMBL23210710

CCOC(=O)c1ccc(Oc2ccc(C3[C@H]4C[C@@H]5C[C@@H](C[C@H]3C5)C4)cc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.48
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
MAOA P21397 1/20 0.48
CA12 O43570 1/20 0.45
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45
ESR1 P03372 1/20 0.45
CA7 P43166 1/20 0.45
CA9 Q16790 1/20 0.45
ESR2 Q92731 1/20 0.45
CA14 Q9ULX7 1/20 0.45
RAB9A P51151 1/20 0.45
STS P08842 1/20 0.45
HPGD P15428 2/20 0.44
MAPK1 P28482 1/20 0.44
RECQL P46063 1/20 0.44
EPHX2 P34913 1/20 0.43
MMP13 P45452 1/20 0.43
PRSS1 P07477 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23210709 1.00 LMNA (0.48) LMNACYP1A2CYP3A4MAOACA12
SCHEMBL21656546 0.86 PDE4B (0.51) LMNACYP1A2CYP3A4MAOAHPGD
SCHEMBL23210615 0.86 PDE4B (0.51) LMNACYP1A2CYP3A4MAOAHPGD
SCHEMBL21628841 0.85 OPRM1 (0.40) LMNACYP1A2CYP3A4MAOACA12
SCHEMBL21628843 0.85 OPRM1 (0.40) LMNACYP1A2CYP3A4MAOACA12
SCHEMBL23210634 0.85 CA1 (0.47) CA12CA1CA2CA7CA9
SCHEMBL21656813 0.85 CA1 (0.47) CA12CA1CA2CA7CA9
SCHEMBL21656506 0.81 ALDH1A1 (0.45) LMNACYP1A2CYP3A4MAOACA12
SCHEMBL25171012 0.81 ALDH1A1 (0.45) LMNACYP1A2CYP3A4MAOACA12
SCHEMBL23210653 0.80 PARP10 (0.49) LMNACA1CA2RAB9AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12600696-B2 Aromatic compounds Xeniopro GmbH (DE) 2026-04-14 US disclosed
US-20230150923-A1 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2023-05-18 US disclosed
US-20210107863-A2 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2021-04-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230150923-A1 NOVEL AROMATIC COMPOUNDS AHR, TYR, MUSK LMNA 3327/4885CYP1A2 458/4885CYP3A4 758/4885
US-20210107863-A2 NOVEL AROMATIC COMPOUNDS AHR, TYR, MUSK LMNA 3327/4885CYP1A2 458/4885CYP3A4 758/4885
US-12600696-B2 Aromatic compounds CCR1, CCRL2, AHR LMNA 832/4885CYP1A2 724/4885CYP3A4 997/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.